🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "targeted action to deal with cost of living pressures" in the upcoming financial statement.

During an interview with the BBC, she noted that lowering price rises is a collective duty of both the administration and the Bank of England.

The United Kingdom's price growth is projected to be the most elevated among the Group of Seven industrialized countries this calendar year and the following year.

Potential Energy Bill Measures

It is understood the government could take action to bring down utility costs, for example by reducing the present 5% level of VAT applied on energy supplies.

Another possibility is to lower some of the regulatory levies currently added to bills.

Fiscal Constraints and Expert Predictions

The government will receive the next report from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much room there is for these actions.

The view from the majority of analysts is that Reeves will have to announce higher taxes or spending cuts in order to meet her voluntary debt limits.

Previously on Thursday, analysis suggested there was a £22bn deficit for the chancellor to fill, which is at the lower end of expectations.

"It is a shared job between the Bank of England and the government to bear down further on some of the sources of price increases," Reeves informed reporters in Washington, at the yearly gatherings of the IMF and global financial institution.

Tax Commitments and International Concerns

While much of the attention has been on likely tax increases, the Treasury chief said the most recent figures from the fiscal watchdog had not changed her pledge to manifesto promises not to raise tax levels on income tax, sales tax or social security contributions.

She attributed an "uncertain global environment" with growing geopolitical and commercial tensions for the Budget tax moves, likely to be directed on those "wealthiest."

International Trade Disputes

Commenting on apprehensions about the UK's commercial links with China she said: "Our security interests invariably take priority."

Recent declaration by China to increase export controls on rare earths and other materials that are crucial for advanced tech manufacturing led US President the US President to threaten an additional 100% tariff on goods from China, increasing the prospect of an full-scale commercial conflict between the two largest economies.

The American finance chief called China's action "commercial pressure" and "a global supply chain power grab."

Questioned on considering the American proposal to join its conflict with the Asian nation, Reeves said she was "deeply worried" by China's measures and called on the Chinese government "not to put up barriers and restrict access."

She said the move was "damaging for the world economy and creates additional obstacles."

"It is my opinion there are sectors where we should confront Chinese policies, but there are also important opportunities to export to Chinese markets, including financial services and other sectors of the economic system. We've got to maintain that balance correct."

The chancellor also affirmed she was cooperating with other major economies "regarding our own essential resources approach, so that we are more independent."

Health Service Drug Pricing and Investment

The Chancellor also admitted that the price the National Health Service spends on pharmaceuticals could rise as a result of current talks with the Trump administration and its drugs companies, in exchange for lower tariffs and capital.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or abandoning investments in the United Kingdom, with several attributing the modest returns they are getting.

Last month, the Science Minister said the cost the health service pays for medicines would need to rise to stop companies and drug research funding leaving the UK.

Reeves informed media: "It has been observed because of the cost structure, that medical research, recent pharmaceuticals have not been offered in the United Kingdom in the extent that they are in other continental states."

"We want to make sure that individuals receiving care from the NHS are can receive the best essential drugs in the globe. And so we are reviewing these issues, and... aiming to obtain additional capital into the UK."